Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Press Micronesia.
Press releases published on July 22, 2025
SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients
GlobeNewswire
·
July 22, 2025
DENVER, July 22, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today positive preliminary results from the SAVE Surveillance Registry which is assessing the use of the …
NKGen Biotech to Present at the Alzheimer’s Association International Conference 2025
GlobeNewswire
·
July 22, 2025
SANTA ANA, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer …
Full Alliance Group and Qubitera Holdings Launch Informational Website for YAHBEE – the First Three Tier Affiliate Cross Chain Wallet built for the GIG Economy
GlobeNewswire
·
July 22, 2025
TAMPA, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group, Inc. (OTC: FAGI) (“the Company”), today announced that its majority-owned subsidiary, Qubitera Holdings, Inc., has officially launched www.yahbee.com, an informational website introducing …
Catalyst Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025
GlobeNewswire
·
July 22, 2025
CORAL GABLES, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for …
Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board
GlobeNewswire
·
July 22, 2025
SYDNEY, July 22, 2025 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, is …
BioVie Appoints Industry Veterans Amy Chappell, MD, FAAN, and Kameel Farag to Board of Directors
GlobeNewswire
·
July 22, 2025
CARSON CITY, Nev., July 22, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver …
LifeVantage Announces Expanded Human Clinical Study for MindBody GLP-1 System™; Findings Increase Average in Natural GLP-1 Production to Over 200%‡‡
GlobeNewswire
·
July 22, 2025
SALT LAKE CITY, July 22, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced new results from its second …
AnswersNow Launches Corporate Advisory Board to Advance Scale of Innovative Virtual Autism Platform
GlobeNewswire
·
July 22, 2025
RICHMOND, Va., July 22, 2025 (GLOBE NEWSWIRE) -- AnswersNow, the leader in virtual Applied Behavioral Analysis (ABA) therapy, today introduced the founding members of its new Corporate Advisory Board. Kim Henrichsen, President of St. Louis University …
Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards for Antibody Drug Conjugates
GlobeNewswire
·
July 22, 2025
SOUTH SAN FRANCISCO, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that it has entered …
aTyr Pharma Announces Last Patient Visit in Phase 3 EFZO-FIT™ Study of Efzofitimod in Patients with Pulmonary Sarcoidosis
GlobeNewswire
·
July 22, 2025
SAN DIEGO, July 22, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase …
More Than 40 American Oncology Network Clinics Across 18 States and Washington, D.C., Now Offering Bispecific T-cell Engager Therapies to Patients
GlobeNewswire
·
July 22, 2025
FORT MYERS, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- American Oncology Network (AON), one of the nation’s fastest-growing networks of community oncology practices, is now offering Bispecific T-cell Engager (BiTE) therapy—also known as BiTE therapy—at more …
Hydreight to Participate in the Canaccord Genuity 45th Annual Growth Conference in Boston
GlobeNewswire
·
July 22, 2025
VANCOUVER, British Columbia, July 22, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS | OTCQB: HYDTF | FSE: SO6) (“Hydreight” or the “Company”), a telehealth and mobile medical company operating across the U.S. focused on expanding access …
Survivor Healthcare Announces the Appointment of Catherine Cowan as Senior Vice President of Clinical Operations
GlobeNewswire
·
July 22, 2025
Cowan will oversee clinical strategy, quality improvement, and expansion of multidisciplinary care teams Appointment strengthens Survivor Healthcare’s mission to deliver integrated, high-quality primary care to cancer survivors with complex needs SALT LAKE …
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on July 24
GlobeNewswire
·
July 22, 2025
SAN DIEGO, July 22, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic …
Madrigal Pharmaceuticals Secures $500 Million in Senior Secured Credit from Blue Owl Managed Funds to Further Extend Leadership Position in MASH
GlobeNewswire
·
July 22, 2025
Proceeds to primarily support MASH pipeline expansion and to refinance existing senior credit facility $350 million initial term loan funded at close and up to an additional $150 million available through 2027 Agreement also provides for the possibility of …
Health care advocates afraid of major cuts and privatization hold rally at Council of the Federation
GlobeNewswire
·
July 22, 2025
HUNTSVILLE, Ontario, July 22, 2025 (GLOBE NEWSWIRE) -- Outside the Council of the Federation and the gathering of First Ministers, public health care advocates from across Canada will be joining a rally and car cavalcade. Attendees include Health …
Pacira BioSciences Announces Strategic Collaboration to Significantly Expand ZILRETTA Promotional Efforts
GlobeNewswire
·
July 22, 2025
Partnership expected to advance 5x30 strategy by increasing ZILRETTA sales calls and extensively expanding patient access BRISBANE, CA, July 22, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery of …
Daxor’s Blood Volume Analysis Technology Accelerates Market Penetration with Three New Facility Adoptions
GlobeNewswire
·
July 22, 2025
Continued Integration of Daxor’s ezBVA Lab Service and On-Site Analyzers Fuels Positive Outlook Oak Ridge, TN, July 22, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces the …
NewAmsterdam Pharma to Present Alzheimer’s Biomarker Data from BROADWAY Trial at AAIC 2025
GlobeNewswire
·
July 22, 2025
NAARDEN, the Netherlands and MIAMI, July 22, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at …
SciSparc Ltd. Regains Compliance with Nasdaq Minimum Bid Price Notification
GlobeNewswire
·
July 22, 2025
Tel Aviv, July 22, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (“SciSparc” or the “Company”) (Nasdaq: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous …